Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Expands By 1,416.7%

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totalling 9,100 shares, an increase of 1,416.7% from the September 15th total of 600 shares. Based on an average trading volume of 4,100 shares, the short-interest ratio is presently 2.2 days.

BIOYF stock opened at $5.62 on Thursday. BioSyent has a 52-week low of $5.13 and a 52-week high of $7.71. The company’s 50 day simple moving average is $5.93 and its 200-day simple moving average is $6.17.

About BioSyent

BioSyent, Inc is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, Tibella, Combogesic, and Cysview. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.

Further Reading: What is the quiet period?

Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.